Detection of minimal residual disease in chronic myeloid leukemia patients after bone marrow transplantation by polymerase chain reaction

Leukemia

Volumn 4, Issue 1, 1990, Pages 1-5

  Delfau, Marie Hélène ^a   Kerckaert, Jean Pierre ^b   D'Hooghe, Maud Collyn ^b   Fenaux, Pierre ^c   Laï, Jean Luc ^c   Jouet, Jean Pierre ^c   Grandchamp, Bernard ^a,d  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Institut de Recherche sur le Cancer de Lille   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d Faculté Bichat   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; FEMALE; HUMAN; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RELAPSE;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; FEMALE; FOLLOW-UP STUDIES; HUMAN; LEUKEMIA, MYELOID, CHRONIC; MALE; POLYMERASE CHAIN REACTION; RECURRENCE; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T;

EID: 0025139759     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Goldman J, Jane F, Galton Dag, et al. Bone marrow transplantation for patients with chronic myeloid leukemia. N Engl J Med 1986;314:202-207.
2. Arthur CK, Apperley JF, Guo AP, Rassool F, Gao LM, Goldman J. Cytogenetic events after bone marrow transplantation for chronic myeloid leukemia in chronic phase. Blood 1988;71:1179-1186.
3. Rowley JD. A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and giemsa staining. Nature 1973;243:290-293.
4. Shtivelman E, Lifshitz B, Gale RP, Roe BA, Canaani E. Alternative splicing of RNAs transcribed from the human c-abl gene and from bcr-abl fused gene. Cell 1986;47:277-284.
5. Groffen J, Stephenson JR, Heisterkamp N, De Klein A, Bartram CR, Grosveld G. Philadelphia chromosomal breakpoint are clustered within a limited region, bcr, on chromosome 22. Cell 1984;36:93-99.
6. Kawasaki ES, Clark SC, Coyne MY, Smith SD, Champlin R, Witte ON, McCormick F. Diagnostic of chronic myeloid and acute lymphocytic leukemias by detection of leukemia specific mRNA sequences amplified in vitro. Proc Natl Acad Sci USA 1988;85:5698-5702.
7. Berger SL, Kimmel AR. Methods in enzymology. Guide to Molecular cloning techniques. San Diego, CA: Academic Press 1987;182.
8. Maniatis T, Fritsch EF, Sambrook J. Molecular cloning. A laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory 1982;280-281.
9. Delfau MH, Garbarz M, Chaveroche I, Grandchamp B. Detection of chimeric abl-bcr mRNA in chronic myelogenous leukemia Med Sci 1988;7:401-403.
10. Berger SL, Kimmel AR. Methods in enzymology. Guide to Molecular cloning techniques. San Diego, CA: Academic Press 1987, 224-225.
11. Konopka JB, Watanabe SM, Witte ON. An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell 1984;37:1034-1042.
12. Morgan GJ, Hughes T, Janssen JWG, Gow J, Guo AP, Goldmann JM, Wiedemann LM, Bartram CR. Polymerase chain reaction for detection of residual leukaemia. Lancet 1989;1:928-929.
13. Kurzrock R, Gutterman JU, Talpaz M. The molecular genetics of Philadelphia chromosome positive leukemias. N Engl J Med 1988;319:990-998.
14. Talpaz M, Kantarjian H, Gutterman JU. Therapy of chronic myelogenous leukemia. Cancer 1987;59:664-667.
15. Opalka B, Klobe O, Bartram CR, Beer U, Janssen JWG, Niederle N, Wandl UB. Elimination by interferon-alpha of malignant clone in chronic myeloid leukaemia. Lancet 1989;1:1334.
16. Lee MS, Chang KS, Freireich EJ, Kantarjian HM, Talpaz M, Trujillo JM, Stass SA. Detection of minimal residual bcr/abl transcripts by a modified polymerase chain reaction. Blood 1988;72:893-897.
17. Lee MS, Le Maistre A, Kantarjian HM, Talpaz M, Freireich EJ, Trujillo JM, Stass SA. Detection of two alternative bcr/abl mRNA junctions and minimal residual disease in Philadelphia positive chronic myelogenous leukemia by polymerase chain reaction. Blood 1989;73:2165-2170.
18. Bartram CR, Janssen JWG, Schmidberger M, Lyons J, Arnold R. Minimal residual leukaemia in chronic myeloid leukaemia patients after T cell depleted bone-marrow transplantation. Lancet 1989;1;1260.
19. Goldman JM, Gale RP, Horowitz MM, et al. Bone marrow transplantation for chronic myelogenous leukaemia in chronic phase: increased risk of relapse associated with T-cell depletion. Ann Intern Med 1988;108:806-814.